Healthcare stocks were lower Wednesday afternoon, with the NYSE Healthcare Index dropping 1.6% and the State Street Health Care Select Sector SPDR ETF (XLV) falling 1.5%.
The iShares Biotechnology ETF (IBB) decreased 0.2%.
In sector news, Oracle (ORCL) said Wednesday it introduced AI agents to help clinical trial teams identify operational risks, recommend actions for review, and coordinate responses across development workflows.
In corporate news, UnitedHealth (UNH) and CPESN USA launched a care model that uses independent community pharmacies to expand access to healthcare, particularly in rural and underserved communities, UnitedHealth said Wednesday. Shares were down past 8%.
BillionToOne (BLLN) shares fell past 5% after a short report by Fuzzy Panda Research. The report alleges that the Tennessee's Office of Program Integrity made a suspected fraud referral to the bureau of investigation into the company's billing in 2024, which remains undisclosed to investors.
Pfizer (PFE) said it has signed a licensing agreement with Starna Therapeutics, under which it obtained exclusive rights outside Greater China to develop, manufacture, and commercialize three treatments for autoimmune diseases. Shares were down 0.9%.
Comments